Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients

Journal of Medical Virology

Volumn 48, Issue 4, 1996, Pages 354-359

  Toyoda, Hidenori ^a   Nakano, Satoshi ^a   Kumada, Takashi ^a   Takeda, Isao ^a   Sugiyama, Keiichi ^a   Osada, Toshimasa ^a   Kiriyama, Seiki ^a   Orito, Etsuro ^b   Mizokami, Masashi ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Branched DNA probe assay; Competitive PCR; HCV; Interferon therapy; Predictive marker

Indexed keywords

HEPATITIS C VIRUS;

ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA PROBE; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; DNA PROBES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSCRIPTION, GENETIC;

EID: 0029928490     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199604)48:4<354::AID-JMV9>3.0.CO;2-6     Document Type: Review

References (27)

1. Chayama K, Tsubota A, Arase Y, Saitoh S, Ikeda IC, Sakai Y, Matsumoto T, Kobayashi M, Unakami M, Morinaga T, Kumada H (1993): Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction. Journal of Gastroenterology and Hepatology 8:S40-S44.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized controlled trial. New England Journal of Medicine 321:1501-1506.
3. Di Bisceglie AM, Martin P, Kassiandies C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989): Recombinant interferon alpha therapy for chronic hepatitis C. New England Journal of Medicine 321;1506-1510.
4. Enomoto N, Takada A, Nakao T, Date T (1990). There are two major types of hepatitis C viruses in Japan. Biochemical and Biophysical Research Communications 170:1021-1025.
5. Gilliland G, Perrin S, Blanchard K, Bunn HF (1990): Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proceedings of National Academy of Science of the United States of America 87:2725-2729.
6. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T (1993): Quantative analysis of hepatitis C virus in serum during interferon alpha therapy. Gastroenterology 104: 877-883.
7. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie AM, Peters M, Waggoner JG, Park Y, Jones EA (1986): Treatment of chronic non-A, non-B, hepatitis with recombinant human alpha Interferon. A preliminary report. New England Journal of Medicine 315: 1575-1578.
8. Kakumu S, Arao M, Yoshioka K, Hayashi H, Kusakabe A, Hirofuji H, Kawabe M (1989): Recombinant human-interferon therapy for chronic non-A, non-B hepatitis: Second report. American Journal of Gastroenterology 85:655-659.
9. Kanai K, Kato M, Okamoto H (1992): HCV genotype in chronic hepatitis C and response to interferon. Lancet 339:1543.
10. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341: 1501-1504.
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers. An application to clinical surveys and tracing infection scores. Journal of General Virology 73:673-679.
12. Omata M, Ito Y, Yokosuka O, Imazeki F, Uchiumi K, Takano S, Hosoda K, Ohto M (1989): Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha: Comparison with histological changes in chronic hepatitis B. Digestive Diseases and Sciences 34:330-337.
13. Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, Mizuno M, Ogino M, Nakamura M, Matsumoto Y, Miyata K, Lau JYN (1994): Serum hepatitis C virus RNA levels as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C. Journal of Medical Virology 44:410-414.
14. Sanchez-Pescador R, Sheridan PJ, Detmer JJ, Hunt WP, Chan CS, Wright T, Okano A, Wilber JC, Neuwald PD, Urdea MS (1992): Quantitative detection of HCV RNA in human sera using a chemoluminescent signal amplification oligonucleotide probe assay. Hepatology 16:588 [Abstract].
15. Sherman KE, O'Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J (1993): Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. Journal of Clinical Microbiology 31:2679-2682.
16. Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y (1991): Serum hepatitis C virus sequences in post-transfusion non-A, non-B hepatitis. Blood 77:1157-1160.
17. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan S-W, Chayama K, Chen D-S, Choo Q-L, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houston M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS (1994): A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
18. Takada N, Takase S, Takada A (1993): Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis. Gastroenterologica Japonica 28:268-275.
19. Takase S, Takada N, Sawada M, Takada A, Okanoue T, Yano M, Yatsuhashi H (1993): Effects of interferon treatment for chronic type C liver diseases with different hepatitis C virus genotypes: A cooperative study in three hospitals. International Hepatology Communications 1.321-325.
20. Thomson BJ, Doran M, Lever AML, Webster ADB (1987): Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gamma-globulin replacement therapy. Lancet 1:539-541.
21. Tsubota A, Chayama K, Ikeda K, Arase Y, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Kumada H (1994): Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
22. Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, Ohba K, Tanaka S, Hattori N, Nomoto A, Kohara M (1993): Antigenicities of group I and II hepatitis C virus polypeptides-molecular basis of diagnosis. Virology 192:430-437.
23. Urdea MS (1993): Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV and HIV. Clinical Chemistry 39:725-726.
24. Urdea MS, Kolberg J, Warner BD (1990): A novel method for the detection of hepatitis B virus in human serum samples without blotting or radioactivity. In van Dyke K, Dyke R (eds): "Luminescence Immunoassay and Molecular Applications." Boca Raton: CRC Press, pp 275-291.
25. Wang AM, Doyle MV, Mark DF (1989): Quantitation of mRNA by the polymerase chain reaction. Proceedings of National Academy of Science of the United States of America 86:9717-9721.
26. Yamada G, Takahashi M, Tsuji T, Yoshizawa H, Okamoto H (1992): Quantitative HCV RNA and effect of Interferon therapy in chronic hepatitis C. Digestive Diseases and Sciences 37:1926-1927.
27. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992): Detection of hepatitis C virus by poiymerase chain reaction and response to interferon alpha therapy: Relation to genotypes of hepatitis C virus Hepatology 16:293-299.